Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
octreotate (2 trials)
²¹²pb-dotam-grpr1 (1 trial)
Neuroendocrine Tumors (Phase 1)
Trials (3 total)
Trial APIs (2 total)